Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Drug-Resistant Hypertension Mechanism
NCT02213575Phase 2Completed
- Sponsor
- University of Florida
- Start
- Mar 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in hypertension (HTN), sponsored by University of Florida. Started Mar 2016; status: completed.
02
Drugs
minocycline
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02213575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02213575.